Europe is buying Trius after the strong conference presentation. The new anti-bacterial drug will support at least a $40 stock valuation. Better get aboard and buy, buy, buy.
strangest stock I've seen in a long time, I'm long and strong, it just doesn't make sense yet.
$40 this year, I think so, do you?
Sentiment: Strong Buy
$40 dollars?? At this point let's hope for $8. We need so major news to get this rolling.
The Germans and Swiss are buying. They are very wise. If they buy we buy and hold for KaBlam!